A monoclonal antibody to a 67 kD cell membrane glycoprotein directly induces persistent platelet aggregation independently of granule secretion
- 1 November 1991
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 79 (3) , 466-473
- https://doi.org/10.1111/j.1365-2141.1991.tb08057.x
Abstract
The transition from reversible to persistent platelet aggregation has been difficult to study because of interference both from preceding primary aggregation and from the events associated with granule secretion during secondary aggregation. As a result it remains unclear whether the persistence of aggregation involves some secretion-independent specific platelet surface reactions. Here we show that a monoclonal antibody (MAb), LeoAl, against a newly described 67 kD platelet membrane glycoprotein induced active platelet aggregation consisting of two distinct phases. The first secretion-independent phase was in several respects (extracellular protein, divalent cation, and pH dependence) different from primary aggregation, but closely resembled the transition from primary to secondary aggregation observed at certain concentrations of physiological agonists. The second, faster phase was indistinguishable from secretion-dependent aggregation to various stimulants. It was shown that p67, GPIIb-IIIa and FC gamma RII are all involved in the observed aggregation, probably through their close topographical association. It is suggested that LeoAl-induced aggregation can be used as a model to study the receptors, ligands and metabolic pathways specifically involved in the transition from reversible to persistent platelet aggregation.Keywords
This publication has 19 references indexed in Scilit:
- Heterogeneity of Platelet Fc-receptor-dependent Response to Activating Monoclonal AntibodiesPlatelets, 1992
- Calcium rise in human platelets elicited by anti-CD9 and -CD41 murine monoclonal antibodiesThrombosis Research, 1989
- Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro.Journal of Clinical Investigation, 1989
- Evidence That Monoclonal Antibodies against CD9 Antigen Induce Specific Association between CD9 and the Platelet Glycoprotein IIb-IIIa ComplexJournal of Biological Chemistry, 1989
- Activation of human monocytes occurs on cross-linking monocytic antigens to an Fc receptor.The Journal of Immunology, 1989
- PL2‐49, a monoclonal antibody against glycoprotein IIb which is a platelet activatorBritish Journal of Haematology, 1989
- von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.Journal of Clinical Investigation, 1986
- TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors.The Journal of Experimental Medicine, 1985
- Interaction of fibrinogen with its platelet receptor: kinetics and effect of pH and temperatureBiochemistry, 1981
- Interrelations of Platelet Aggregation and SecretionJournal of Clinical Investigation, 1977